Bournas CEO Departures Pharmaceutical group CEO steps down John Bournas left the International Society of Pharmaceutical Engineering, effective Jan. 8, after five years as CEO. The $13M-revenue group has appointed as acting CEO Tim Howard, a former ISPE board chair, while the board begins a search for a permanent replacement. Howard is taking a leave from his position at CAI, a company that provides engineering, technical and consulting services. Bournas previously was CEO of the World Federation of Hemophilia and senior director of international affairs at the American College of Cardiology Foundation. Kreizman to exit AACC Janet Kreizman will retire as CEO of the… Read More